XRP scored every major win in 2025 with the SEC case resolved and spot ETFs launched, yet the price crashed 50%, with the $5 target remaining elusive.
You might also be interested in reading Amylyx Pharmaceuticals Q2 2025 Earnings Preview.
XRP scored every major win in 2025 with the SEC case resolved and spot ETFs launched, yet the price crashed 50%, with the $5 target remaining elusive.
You might also be interested in reading Amylyx Pharmaceuticals Q2 2025 Earnings Preview.